BMG Pharma

About:

BMG Pharma is a pharmaceuticals company and the first to develop patented biomaterials based on modified Sodium Hyaluronate.

Website: https://www.bmgpharma.com

Top Investors: Friulia Finanziaria FVG

Description:

BMG Pharma S.p.A.is an Italian pharmaceutical company and the first company in the world to develop products based on modified Sodium Hyaluronate, a patent protected technology which they brand as hyaluromimethic technology. BMG headquarters is currently located in Milan, Italy. It is a business to business company and its business model is based on signing distribution and licensing agreements with companies worldwide to sell and distribute its products. In 2018, BMG acquired another Italian company, Sigea S.r.l, with expertise in the development of targeted functional ingredients, specifically focused on modified Hyaluronic Acid (Sodium Hyaluronate).